Canada markets close in 57 minutes

BDX Jan 2025 290.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.50000.0000 (0.00%)
As of 12:43PM EDT. Market open.
Full screen
Loading interactive chart...
  • Zacks

    BD (BDX) Up on Efforts to Tackle Blood Culture Vial Shortage

    BD (BDX) faces a shortage of blood culture vials due to supplier issues. It is ramping up production and collaborating with the FDA to ensure patient care remains unaffected.

  • PR Newswire

    BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to a U.S. FDA letter to health care providers regarding the supply of blood culture vials:

  • PR Newswire

    BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 science-based greenhouse gas (GHG) emissions reduction targets for FY 2023 by 5 percentage points and received approval for near and long-term science-based emissions reduction targets from the Science Based Target initiative (SBTi)[1]. This furthers the company's progress toward its goal to reach net zero GHG emissions across its value chain by FY 2050.